Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor
Ann Rheum Dis
.
2019 Jul;78(7):e70.
doi: 10.1136/annrheumdis-2018-213672.
Epub 2018 May 14.
Authors
Karmela Kim Chan
1
,
Anne R Bass
1
Affiliation
1
Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA.
PMID:
29760158
DOI:
10.1136/annrheumdis-2018-213672
No abstract available
Keywords:
T cells; autoimmunity; polymyalgia rheumatica.
Publication types
Letter
Kommentar
MeSH terms
Azetidines
Giant Cell Arteritis*
Humans
Neoplasms*
Piperidines
Polymyalgia Rheumatica*
Prospective Studies
Substances
Azetidines
Piperidines
cobimetinib